The Innovative Medicines Initiative (IMI) is a partnership between the European Union and the European pharmaceutical industry. IMI facilitates open collaboration in research to advance the development of, and accelerate patient access to, personalised medicines for the health and wellbeing of all, especially in areas of unmet medical need.
Find out more: www.imi.europa.eu
EFPIA: www.efpia.eu
European Commission Research & Innovation: http://ec.europa.eu/research/index.cfm
Please send an email to: info@imi-neuronet.org